直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Special Report: Trends in Federal Circuit PTAB Appeals Through 2023

April 19, 2024

Authored and Edited by Daniel F. Klodowski; Audrey J. Parker; Jason E. Stach; Elliot C. Cook

In this special report, we review trends over time in PTAB post-grant appeals to the Federal Circuit.  Through December 31, 2023, the Federal Circuit cumulatively decided 1,247 appeals from the PTAB in IPRs, CBMs, and PGRs.  Yet the number of opinions in PTAB appeals has not remained constant over time; in 2015, the first year it heard appeals from AIA post-grant proceedings, the Federal Circuit issued only 47 opinions.  That number rose steadily over time to a peak in 2019, when the Federal Circuit issued 190 opinions.  The rate of opinion issuance then decreased over time, falling to 119 opinions in 2022 before increasing again to 150 opinions issued in 2023.

The composition of PTAB post-grant appeals has also changed over time.  IPRs have consistently represented the vast majority of post-grant proceedings appealed to the Federal Circuit, but CBM appeals began with 5 opinions issued in 2015 before reaching a peak in of 12 opinions issued in 2017.  The number of CBM appeals then tapered over time.  By 2023, the Federal Circuit did not issue any opinions for CBM appeals, reflecting Congress’s sunsetting of the CBM program in 2020 (although notably, two CBM appeals have already issued in 2024).  As the number of CBM appeals waned, the Federal Circuit gradually began issuing opinions for PGR appeals, beginning with one PGR appeal in 2018 and increasing to 7 opinions issued in 2023.

Through the end of 2023, the Federal Circuit affirmed every issue on appeal in 925 (74.18%) cases and issued a mixed outcome, in which some issues were affirmed and others were reversed or vacated, in 125 (10.02%) cases.  The court reversed or vacated every issue on appeal in 156 (12.51%) cases and dismissed 41 (3.29%) cases on non-settlement grounds, such as due to the court’s stated lack of jurisdiction for appeals of PTAB institution decisions.

The outcomes in PTAB post-grant appeals have also varied significantly over the past nine years.  In 2015, the Federal Circuit affirmed every issue on appeal in about 83% of its opinions.  The affirmance rate then fell to 70.5% by 2017 before remaining consistently between 70-75% from 2017 through 2022.  In 2023, the court’s affirmance rate for every appealed issue, however, rose sharply to a peak of 83.3%.  The Federal Circuit’s rate of reversing or vacating every issue in PTAB post-grant appeals has not exceeded 20%, reaching a peak of 17.4% in 2019.  The rate of mixed outcomes has similarly remained relatively low over time, peaking at about 13% in 2020, and the ratio of dismissals has hovered in the low single-digits after peaking at 8.5% in 2015.

In cases that it deems lacking in precedential value, the Federal Circuit may issue a summary (one-line) affirmance under Federal Circuit Rule 36.  Of the 1,247 IPR, CBM, and PGR appeal opinions issued through 2023, the Federal Circuit issued Rule 36 affirmances in 532 (42.66%) cases.  The court issued written opinions, including affirmances, reversals, dismissals, and mixed decisions, in 715 (57.34%) cases. 

The rate of Rule 36 affirmances has generally decreased over time.  The Federal Circuit issued summary affirmances in 55% of its opinions in 2015 before sharply decreasing to 38% in 2017.  After increasing in 2018-2019, the rate of Rule 36 affirmances again dropped, settling at a summary affirmance rate of 40% in 2023.  This trend of decreasing Rule 36 affirmances is particularly noteworthy given the overall increase in the Federal Circuit’s rate of affirming on every issue; while the overall affirmance rate (for every appealed issue) rose to 83.3% in 2023, a historic high, the rate of summary affirmance nevertheless remained relatively low, reflecting the long-term trend of summary affirmances becoming less common at the court. 

 

For more information

Click here to listen to the podcast that further discusses the statistics. 

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Offices

Atlanta, GA

Reston, VA

Washington, DC

Contacts

Daniel F. Klodowski
Partner
Washington, DC
+1 202 408 4216
Email
Jason E. Stach
Partner
Atlanta, GA
+1 404 653 6428
Email
Elliot C. Cook
Partner
Reston, VA
+1 571 203 2738
Email

Copyright © 2024 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Federal Circuit IP Blog

When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case

May 14, 2026

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

Workshop

Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 7, 2026

Cambridge

IP Updates

Tenth Circuit Sides with Netflix in Tiger King Copyright Challenge 

May 5, 2026

Conference

International Trade Commission Litigation & Enforcement

May 4-5, 2026

Washington, DC

Articles

Choice of Law in Patent Appeals: The Federal Circuit’s Issue-by-Issue Framework

May/June 2026

Articles

Unpacking Squires’ Recent Discretionary Denial Guidance Focusing on American Manufacturing

April 24, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP